Neostigmine-spl-carton-1-10 (Neostigmine Spl Carton 1 10)
Neostigmine Methylsulfate Injection
Product Images NDC 68083-384
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 68083-384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Neostigmine-spl-carton-1 (Neostigmine Spl Carton 1)
Neostigmine-spl-carton-5-1 (Neostigmine Spl Carton 5 1)
Neostigmine Methylsulfate Injection, USP is a medication that is used for the treatment of certain conditions related to muscle weakness and myasthenia gravis. It is administered via injection in dosages of 10 Mot Dose or 10 Muttpe ose for maintenance use.*
Neostigmine-spl-carton-5-10 (Neostigmine Spl Carton 5 10)
Neostigmine-spl-structure (Neostigmine Spl Structure)
Neostigmine-spl-vial-1 (Neostigmine Spl Vial 1)
Neostigmine Methylsulfate Injection, USP is a medication administered via intravenous use, with concentration of 1mg/ml and packaged in a multiple dose vial of 10ml. It should be stored at room temperature and protected from light. Specific storage instructions are provided on the packaging including a lot number and expiry date.*
Neostigmine-spl-vial-5 (Neostigmine Spl Vial 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
